期刊文献+

PEG修饰对尿酸酶酶学性质的影响 被引量:5

Effect of PEGylation on Properties of Uricase
原文传递
导出
摘要 对Candida utilis来源的尿酸酶进行定点修饰,并对修饰前后尿酸酶酶学性质的改变进行了研究。PEG修饰使尿酸酶的最适pH往中性偏移,最适温度反应曲线展宽,与底物亲和力增加但最大反应速率降低,在低离子强度条件下更加稳定,对尿酸酶结合金属离子及阴离子的能力有弱化作用。研究结果显示:PEG修饰不仅可以通过屏蔽效应改善尿酸酶的药代动力学性质,也可能通过影响尿酸酶亚基解离、亚基表面电荷分布等性质而影响尿酸酶的酶学性质。这些结果为新药开发PEG-尿酸酶提供了基础。 In our study the Escherichia Coli to express the recombinant Candida utilis uricase,was ased and modified at N-terminal by site-specific PEGylation with PEG-ALD-20000, and the change of enzymology character of the conjugate after PEGylation was also studied systematically. The results showed that, compared to nature uricase, optimal pH value of conjugate had a migration to neutral pH value, the curve of optimal temperature was boarder, substrate affinity increased but the Vmax reduced, more stable in low ionic strength environment, and the capability of binding negative ion and metal ion were weak. From these results it could be concluded that PEGylation could improve the pharmacokinetics properties of uricase not only by shielding effect, also by the effect on the subunit dissociation and charge distribution on the subunit surface. These results provide a basis on the rational design and new drug development of PEG-uricase.
出处 《药物生物技术》 CAS CSCD 2011年第6期488-491,共4页 Pharmaceutical Biotechnology
基金 国家自然科学基金资助项目(NO.30772679 30973667)
关键词 尿酸酶 PEG修饰 定点修饰 Uricase, PEGylation, Site-specific modification
  • 相关文献

参考文献2

二级参考文献22

  • 1Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol [ J ]. Joint Bone Spine, 2004,71 ( 6 ) : 481 - 485.
  • 2Nuki G. Treatment of crystal arthropathy--history and advances [ J]. Rheum Dis Clin North Am,2006,32 (2) :333 -357.
  • 3Brogard JM, Coumams D, Frankhauser J, et al. Enzymatic uricoly- sis : a study of the effect of a fungal urate-oxydase [ J ]. Rev Eur Etud Clin Biol, 1972,17 (9) : 890 - 895.
  • 4Schellekens H. Immunogenicity of therapeutic proteins: clinical implications and future prospects[ J ]. Clin Ther, 2002,24 (11 ) : 1 720-1 740.
  • 5Roberts M J, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation [ J ]. Adv Drug Deliver Rev ,2002 ,54 (4) : 459 - 476.
  • 6Greenwald RB, Choe YH, McGuire J, et al. Effective drug delivery by PEGylated drug conjugates [ J ]. Adv Drug Deliver Rev,2003, 55(2) :217 -250.
  • 7Veronese FM, Pasut G. PEGylation, successful approach to drug delivery [ J ]. Drug Discov Today,2005,10 ( 21 ) : 1 451 - 1 458.
  • 8Robert H, Chen L, Abuchowski A, et al. Properties of two urate oxidases modified by the covalent attachment of poly (ethylene glycol) [ J ]. Biochim Biophys Acta, 1981,660 ( 2 ) : 293 - 298.
  • 9Davis S, Park YK. Abuchowski A, et al. Hypouricaemic effect of polyethylene glycol modified urate oxidase [ J ]. Lancet, 1981,2 (8 241) :281 -283.
  • 10Gong XW, Wei DZ, He ML, et al. Discarded free PEG-based assay for obtaining the modification extent of pegylated proteins [ J]. Talanta,2007,71 ( 1 ) :381 - 384.

共引文献7

同被引文献49

  • 1于青琳.芽胞杆菌尿酸酶的制备及鉴定[J].临床检验杂志,1994,12(3):125-126. 被引量:4
  • 2刘广桢,陈建华,王旻.尿酸酶产生菌的筛选、基因克隆及表达[J].中国药科大学学报,2005,36(5):464-467. 被引量:10
  • 3吕程.β-乳球蛋白的结构特性及其在食品工业中的应用[J].黄牛杂志,2005,31(6):36-39. 被引量:6
  • 4Krantz SB. Erythmpoietin [ J ]. Blood, 1991,77 ( 3 ) :419.
  • 5Winearls CG, Oliver DO, Pippard MJ,et al. Effect of human eryth- ropoietin derived from recombinant DNA on anemic of patients maintained by the chronic haemodialysis [ J ]. Lancet, 1986,328 (8517) :1175.
  • 6Sasaki H, Bothner B, Dell A, et al. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA [ J ]. J Bio Chem, 1987, 262 (25) :12059.
  • 7Luca DN, Giuseppe C, Paolo C, et aL Stability of target Hemoglo- bin levels during the first year of Epoetin treatment in patients with chronic kidney disease[J]. Clin J Am Soc Nephrol,2007,2 (5) :938.
  • 8Franeesco MV. PEGylated Protein Drugs:Basic Science and Clinical Applicatioas [ M]. The First Edition, Switzerland : Birkhauser Basel, 2009,10.
  • 9Bunn HF. New agents that stimulate erythropoiesis [ J ]. Blood, 2007,109(3 ) :868.
  • 10Lucia DV, Andrea C, Francesco L. Methoxypolyethylene glycole- poetin beta for the treatment of anemia associated with chronic kidney disease [ J ]. Drugs of Today,2008,44 ( 8 ) :577.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部